MarketPeel
Insider Trading Intelligence
Pricing
…
JD

Joanne M. Donovan

EWTX
CMO · EDGEWISE THERAPEUTICS, INC. · CIK 0001644087
FILING MIX · LIFETIME46%/54%
BUYS
17
SELLS
20
TOTAL VALUE
$6.21M
COMPANIES
1
ACTIVE SINCE
Apr 2021
HOLDINGS NOW
54,367
AVG SELL PX
$31.56
TRADE KIND
SHOWING 37 / 37
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
12 backtested trades · 8 horizons · 25 pending
Forward-return performance of every backtestable P/S trade by Joanne M. Donovan, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d12+33.33%+1.75%+1.55%+0.20%+2.66%—
14d12+33.33%-0.04%+3.82%-2.28%-0.73%—
30d12+66.67%+1.95%+5.96%-5.26%-12.83%—
60d12+25.00%+2.47%+3.74%-2.98%-3.34%—
90d12(2 pending)+40.00%+6.63%+8.98%-2.35%+8.02%—
180d12(6 pending)+66.67%+19.56%+8.81%+10.75%-18.51%—
1y12(7 pending)+40.00%+27.91%+19.46%+8.45%-12.22%—
2y12(10 pending)+0.00%+74.66%+42.08%+32.57%+32.57%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
EWTX · 54,367 shares · as of May 5, 2026
060,000120,000180,000240,00020222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 17 buys / 20 sellsCOVERAGE · 21 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
CMO
50,000$38.57$1.93M4,367May 5, 2026May 4, 2026 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
CMO
50,000——75,000May 5, 2026May 4, 2026 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
CMO
50,000$7.08$354.0K54,367May 5, 2026May 4, 2026 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
CMO
5,230$31.29$163.7K4,367May 4, 2026May 4, 2026 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
28,662$32.31$926.1K9,597Apr 1, 2026Apr 1, 2026 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
CMO
28,662——125,000Apr 1, 2026Apr 1, 2026 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
CMO
28,662$7.08$202.9K38,259Apr 1, 2026Apr 1, 2026 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
CMO
21,338——153,662Mar 31, 2026Mar 31, 2026 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
21,338$32.12$685.3K9,597Mar 31, 2026Mar 31, 2026 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
CMO
21,338$7.08$151.1K30,935Mar 31, 2026Mar 31, 2026 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
9,623$30.98$298.1K16,332Mar 27, 2026Mar 30, 2026 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
6,735$30.98$208.6K9,597Mar 27, 2026Mar 30, 2026 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
CMO
5,781——28,223Aug 12, 2025Aug 14, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
CMO
2,862$13.39$38.3K25,361Aug 12, 2025Aug 14, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
CMO
5,781——17,344Aug 12, 2025Aug 14, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
28,125——28,125Aug 12, 2025Aug 14, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
168,750——168,750Aug 12, 2025Aug 14, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
CMO
5,187$16.45$85.3K21,588May 2, 2025May 7, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
CMO
10,417——0May 1, 2025May 7, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
CMO
10,417——26,775May 1, 2025May 7, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
25,000$27.63$690.7K16,358Jan 28, 2025Jan 30, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
CMO
25,000——175,000Jan 28, 2025Jan 30, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
CMO
25,000$7.08$177.0K41,358Jan 28, 2025Jan 30, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
CMO
7,162$28.29$202.6K14,538Sep 20, 2024Sep 24, 2024 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
23,125——23,125Aug 12, 2024Aug 14, 2024 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
138,750——138,750Aug 12, 2024Aug 14, 2024 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
CMO
3,682$18.91$69.6K19,897May 2, 2024May 3, 2024 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
CMO
10,417——23,579May 1, 2024May 3, 2024 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
CMO
10,417——10,417May 1, 2024May 3, 2024 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
200,000——200,000Aug 17, 2023Aug 18, 2023 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
CMO
3,254$8.90$29.0K9,960May 2, 2023May 3, 2023 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
CMO
10,416——20,834May 1, 2023May 3, 2023 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
CMO
10,416——13,214May 1, 2023May 3, 2023 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
240,000——240,000Aug 8, 2022Aug 10, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
31,250——31,250May 1, 2022May 3, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
160,000——160,000Aug 17, 2021Aug 19, 2021 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
160,000——160,000Apr 30, 2021May 4, 2021 ↗View →
Other insiders · EWTX
Loading peer insiders…
About this filer
CIK 0001644087
ROLE
CMO
PRIMARY
EWTX
COMPANIES
1
ACTIVE SINCE
Apr 2021
MARKETPEEL · /INSIDER/0001644087DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback